Cross NA - Search Results

1

Characterization of an Aggregated Three-Dimensional Cell Culture Model by Multimodal Mass Spectrometry Imaging.

Flint LE, Hamm G, Ready JD, Ling S, Duckett CJ, Cross NA, Cole LM, Smith DP, Goodwin RJA, Clench MR. Flint LE, et al. Among authors: cross na. Anal Chem. 2020 Sep 15;92(18):12538-12547. doi: 10.1021/acs.analchem.0c02389. Epub 2020 Aug 14. Anal Chem. 2020. PMID: 32786495 Free PMC article.

2

MALDI-MSI for the analysis of a 3D tissue-engineered psoriatic skin model.

Harvey A, Cole LM, Day R, Bartlett M, Warwick J, Bojar R, Smith D, Cross N, Clench MR. Harvey A, et al. Proteomics. 2016 Jun;16(11-12):1718-25. doi: 10.1002/pmic.201600036. Proteomics. 2016. PMID: 27226230 Free PMC article.

3

Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture model.

Palubeckaitė I, Crooks L, Smith DP, Cole LM, Bram H, Le Maitre C, Clench MR, Cross NA. Palubeckaitė I, et al. Among authors: cross na. J Mass Spectrom. 2020 Apr;55(4):e4461. doi: 10.1002/jms.4461. Epub 2019 Dec 2. J Mass Spectrom. 2020. PMID: 31654532

4

Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants.

Spencer CE, Flint LE, Duckett CJ, Cole LM, Cross N, Smith DP, Clench MR. Spencer CE, et al. Expert Rev Proteomics. 2020 Nov-Dec;17(11-12):827-841. doi: 10.1080/14789450.2021.1876568. Epub 2021 Feb 2. Expert Rev Proteomics. 2020. PMID: 33440126 Free PMC article. Review.

5

Comparison of Osteosarcoma Aggregated Tumour Models with Human Tissue by Multimodal Mass Spectrometry Imaging.

Flint LE, Hamm G, Ready JD, Ling S, Duckett CJ, Cross NA, Cole LM, Smith DP, Goodwin RJA, Clench MR. Flint LE, et al. Among authors: cross na. Metabolites. 2021 Jul 31;11(8):506. doi: 10.3390/metabo11080506. Metabolites. 2021. PMID: 34436447 Free PMC article.

6

Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response.

Pearce SM, Cross NA, Smith DP, Clench MR, Flint LE, Hamm G, Goodwin R, Langridge JI, Claude E, Cole LM. Pearce SM, et al. Among authors: cross na. Metabolites. 2024 May 29;14(6):315. doi: 10.3390/metabo14060315. Metabolites. 2024. PMID: 38921450 Free PMC article.

7

Volatile organic compound analysis of malignant pleural mesothelioma chorioallantoic membrane xenografts.

Little LD, Barnett SE, Issitt T, Bonsall S, Carolan VA, Allen E, Cole LM, Cross NA, Coulson JM, Haywood-Small SL. Little LD, et al. Among authors: cross na. J Breath Res. 2024 Sep 11;18(4):046010. doi: 10.1088/1752-7163/ad7166. J Breath Res. 2024. PMID: 39163890 Free PMC article.

8

Biological and structural studies of phosphonium 'masked thiolate' compounds.

Chen YS, Allen DW, Tizzard GJ, Pitak MB, Coles SJ, Cross NA, Bricklebank N. Chen YS, et al. Among authors: cross na. Eur J Med Chem. 2017 Jan 5;125:528-537. doi: 10.1016/j.ejmech.2016.08.025. Epub 2016 Aug 18. Eur J Med Chem. 2017. PMID: 27710828 Free article.

9

SAHA-induced TRAIL-sensitisation of Multiple Myeloma cells is enhanced in 3D cell culture.

Arhoma A, Chantry AD, Haywood-Small SL, Cross NA. Arhoma A, et al. Among authors: cross na. Exp Cell Res. 2017 Nov 15;360(2):226-235. doi: 10.1016/j.yexcr.2017.09.012. Epub 2017 Sep 8. Exp Cell Res. 2017. PMID: 28890292 Free article.

10

The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment.

Hudson K, Cross N, Jordan-Mahy N, Leyland R. Hudson K, et al. Front Immunol. 2020 Oct 21;11:568931. doi: 10.3389/fimmu.2020.568931. eCollection 2020. Front Immunol. 2020. PMID: 33193345 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters